HNI Stock Analysis: HNI | NYSE
Furnishings, Fixtures & Appliances | NYSE, USA | Market Cap: 3.386m USD | 12M Return: 8% | US4042511000 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 24.4M
EPS Trend: 89.1%
Qual. Beats: 1
Rev. Trend: 77.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
HNI Corporation is a U.S.-based manufacturer operating in two segments: Workplace Furnishings and Residential Building Products, with primary operations in the United States and Canada. Headquartered in Muscatine, Iowa, and incorporated in 1944, the company markets its products under a broad portfolio of well-known brands such as HON, Kimball, HBF, Allsteel, Coalesse, National, Gunlocke, and others. HNI is classified under the GICS Industrials sector, specifically within the Office Services & Supplies sub-industry, and competes in a market environment that includes large peers such as Steelcase and Haworth. The Workplace Furnishings segment sells panel-based and freestanding furniture systems, seating, tables, storage, and architectural products through independent dealers, company-owned dealers, office product distributors, and direct-to-customer and government channels. The Residential Building Products segment provides gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits, and accessories through independent dealers, distributors, and corporation-owned retail and installation outlets.
- Workplace Furnishings revenue tied to office return and corporate capex
- Residential Building Products demand pressured by higher mortgage rates
- Input cost inflation compresses margins across both segments
| Net Income: 4.30m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -11.02 > 1.0 |
| NWC/Revenue: 8.54% < 20% (prev 7.24%; Δ 1.30% < -1%) |
| CFO/TA 0.01 > 3% & CFO 28.8m > Net Income 4.30m |
| Net Debt (1.84b) to EBITDA (331.8m): 5.54 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (72.1m) vs 12m ago 53.08% < -2% |
| Gross Margin: 40.01% > 18% (prev 40.22%; Δ -0.21% > 0.5%) |
| Asset Turnover: 130.5% > 50% (prev 135.0%; Δ -4.49% > 0%) |
| Interest Coverage Ratio: 2.0 > 6 (EBIT TTM 133.8m / Interest Expense TTM 66.9m) |
| A: 0.08 (Total Current Assets 1.41b - Total Current Liabilities 1.04b) / Total Assets 4.82b |
| B: 0.11 (Retained Earnings 551.4m / Total Assets 4.82b) |
| C: 0.04 (EBIT TTM 133.8m / Avg Total Assets 3.36b) |
| D: 0.60 (Book Value of Equity 1.81b / Total Liabilities 3.01b) |
| Altman-Z'' = 1.78 = BBB |
| DSRI: 1.26 (Receivables 629.4m/293.6m, Revenue 4.39b/2.58b) |
| GMI: 1.01 (GM 40.22% / 40.01%) |
| AQI: 1.25 (AQ_t 0.44 / AQ_t-1 0.35) |
| SGI: 1.70 (Revenue 4.39b / 2.58b) |
| TATA: -0.01 (NI 4.30m - CFO 28.8m) / TA 4.82b) |
| Beneish M = -2.15 (Cap -4..+1) = BB |
As of October 15, 2026, the stock is trading at USD 46.43 with a total of 561,724 shares traded. Over the past week, the price has changed by -0.11%, over one month by -0.58%, over three months by +17.81% and over the past year by +7.97%.
Current recommended Stop Loss: 44.00 (which is 5.2% or 1.8 ATR below the current price).
HNI has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy HNI.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 71 | 52.9% |
P/E Forward = 10.02
P/S = 0.7709
P/B = 1.9109
P/EG = 0.5009
Revenue TTM = 4.39b USD
EBIT TTM = 133.8m USD
EBITDA TTM = 331.8m USD
Long Term Debt = 1.36b USD (from longTermDebt, last quarter)
Short Term Debt = 120.6m USD (from shortTermDebt, last quarter)
Debt = 1.95b USD (from shortLongTermDebtTotal, last quarter) + Leases 268.9m
Net Debt = 1.84b USD (calculated: Debt 1.95b - CCE 108.2m)
Enterprise Value = 5.22b USD (3.39b + Debt 1.95b - CCE 108.2m)
Interest Coverage Ratio = 2.0 (Ebit TTM 133.8m / Interest Expense TTM 66.9m)
EV/FCF = -50.66x (Enterprise Value 5.22b / FCF TTM -103.1m)
FCF Yield = -1.97% (FCF TTM -103.1m / Enterprise Value 5.22b)
FCF Margin = -2.35% (FCF TTM -103.1m / Revenue TTM 4.39b)
Net Margin = 0.10% (Net Income TTM 4.30m / Revenue TTM 4.39b)
Gross Margin = 40.01% ((Revenue TTM 4.39b - Cost of Revenue TTM 2.63b) / Revenue TTM)
Gross Margin QoQ = 43.96% (prev 34.60%)
Tobins Q-Ratio = 1.08 (Enterprise Value 5.22b / Total Assets 4.82b)
Interest Expense / Debt = 3.44% (Interest Expense 66.9m / Debt 1.95b)
Taxrate = 28.23% (20.1m / 71.2m)
NOPAT = 96.0m (EBIT 133.8m * (1 - 28.23%))
Current Ratio = 1.36 (Total Current Assets 1.41b / Total Current Liabilities 1.04b)
Debt / Equity = 1.08 (Debt 1.95b / totalStockholderEquity, last quarter 1.81b)
Debt / EBITDA = 5.54 (Net Debt 1.84b / EBITDA 331.8m)
Debt / FCF = -17.82 (negative FCF - burning cash) (Net Debt 1.84b / FCF TTM -103.1m)
Total Stockholder Equity = 1.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.13% (Net Income 4.30m / Total Assets 4.82b)
RoE = 0.28% (Net Income TTM 4.30m / Total Stockholder Equity 1.56b)
RoCE = 4.58% (EBIT 133.8m / Capital Employed (Equity 1.56b + L.T.Debt 1.36b))
RoIC = 2.53% (NOPAT 96.0m / Invested Capital 3.79b)
WACC = 6.84% (E(3.39b)/V(5.33b) * Re(9.36%) + D(1.95b)/V(5.33b) * Rd(3.44%) * (1-Tc(0.28)))
Discount Rate = 9.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 72.08 | Cagr: 19.71%
[DCF] Fair Price = unknown (Cash Flow -103.1m)
EPS Correlation: 89.11 | EPS CAGR: 14.75% | SUE: 2.31 | # QB: 1
Revenue Correlation: 77.57 | Revenue CAGR: 17.08% | SUE: -0.06 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.40 | Chg30d=+0.00% | Revisions=+50% | Analysts=4
EPS current Year (2026-12-31): EPS=4.24 | Chg30d=-0.29% | Revisions=+50% | GrowthEPS=+22.6% | GrowthRev=+110.8%
EPS next Year (2027-12-31): EPS=4.80 | Chg30d=-0.67% | Revisions=+0% | GrowthEPS=+13.2% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: +55% (up=7, down=1)